ArticleCell discovery2026

ASO-based PKM splice-switching therapy increases anti-CTLA-4 antibody efficacy in pancreatic ductal adenocarcinoma.

Lijie Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.